Pathstone Family Office’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
Other funds holding NGVT
ICP
SAM
Pathstone Family Office's NGVT Position: Q3 2023 in Review
Pathstone Family Office increased its Ingevity (NGVT) stake by 22% in Q3 2023, buying an estimated $43.8K and bringing the position to 4,430 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #1490.
Pathstone Family Office first reported a position in NGVT in Q1 2017 and has held it in 11 quarters since. The position peaked at $877K in Q3 2022. 258 funds tracked by Wall St. Rank hold NGVT as of Q3 2023.
- Pathstone Family Office held 4,430 shares of Ingevity worth $211K as of Q3 2023.
- Pathstone Family Office bought 803 Ingevity shares in Q3 2023, an estimated $43.8K.
- Ingevity made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1490 holding.
- Pathstone Family Office first reported a position in Ingevity in Q1 2017 and has held it in 11 quarters since.
- Pathstone Family Office's Ingevity position peaked at $877K in Q3 2022.
- 258 funds tracked by Wall St. Rank held Ingevity as of Q3 2023.
Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.